We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, James F. Howard is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 1985 — 1989 |
Howard, James F [⬀] |
K07Activity Code Description:
To create and encourage a stimulating approach to disease curricula that will attract high quality students, foster academic career development of promising young teacher-investigators, develop and implement excellent multidisciplinary curricula through interchange of ideas and enable the grantee institution to strengthen its existing teaching program. |
Variations in Neuromuscular Safety Factor @ University of North Carolina Chapel Hill
Myasthenia gravis (MG), a postsynaptic disorder of neuromuscular transmission, is characterized by exertional weakness which is improved with rest. Uniquely there is a predilection for weakness of the ocular and oculorotatory muscles. Appropriate immunosuppressive therapy may be delayed because of the restricted presentation of this disorder. The cause of this differential weakness is not known. Speculation and some data suggests that the safety factor (the susceptibility to functional weakness) of neuromuscular transmission is reduced in muscles of ocular motility. In order to elucidate those physiologic factors which might account for this variability the quantal components and kinetics of neurotransmitter release will be examined in representative ocular, respiratory and appendicular muscles from animals with "high" and "low" safety factors. The characteristics of synaptic transmission will be examined in animals with experimental autoimmune myasthenia gravis (EAMG) to determine whether there is a predilection of attack for the ocular muscles. Single fiber electromyography, a clinical neurophysiological index known to correlate with the clinical course of MG, will be examined in these muscles and correlated with the intracellular physiology of neuromuscular transmission. The density of acetylcholine receptors in these muscles of animals with "high" and "low" safety factors will be determined to see if differences do exist. Comparisons will be made with animals with EAMG to determine if there is a predilection of attack and finally the characteristics of myasthenic antibody binding to these receptors will be examined to see if there is a specificity of ocular antibody to ocular muscle.
|
1 |